NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/31/2024
Back to search
Official data from USPTO
PALYNZIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/31/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/05/2017
Registration date
10/02/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/02/2018
First use in commerce
07/02/2018
Drawing code
5
Owner type
03
Owner location
Novato, CA
Examiner
FAHRENKOPF, PAUL
Current location
Historical data usage
Mark description
The mark consists of an upper-case of letter "P" and the lower-case letters of "alynziq".
Holders and representatives
Holders
Biomarin Pharmaceutical Inc.
Representatives
Gregory J. Chinlund Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/31/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/30/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/29/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/28/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/21/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/20/2018
IUAF
USE AMENDMENT FILED
07/23/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/23/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/30/2018
EX1G
SOU EXTENSION 1 GRANTED
06/28/2018
EXT1
SOU EXTENSION 1 FILED
06/28/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/28/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2017
DOCK
ASSIGNED TO EXAMINER
09/28/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2017
NWAP
NEW APPLICATION ENTERED
07/08/2017
Continuous trademark protection
Get notified about every new filing that threatens PALYNZIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.